SoracteLite in UK
Ideal Medical Solutions, exclusive distributor of Elesta #EchoLaser in UK/IRE, has launched a campaign to increase awareness on Benign Prostatic Hyperplasia, a disease which affects 1 out of 2 males above 50 years.
Patients can scan a QR Code and book a free consultation.
SIU 2022
Elesta is gaining visibility i n the Urology space: we are sponsor of the SIU (Società Italiana di Urologia) national congress in Riccione these days. EchoLaser is a game changer for the outpatient, non surgical treatment of Benign Prostatic Hyperplasia.
The final meeting on Delphi Consensus on SoracteLite™ TPLA for BPH and Pca was held on 26 September 2022
Expert users of EchoLaser for the treatment of BPH – Benign Prostatic Hyperplasia and for focal therapy of prostatic carcinoma (SoracteLite™ TPLA – Transperineal Laser Ablation) gathered yesterday in Florence to finalize a Delphi Consensus project which was initiated months ago and will soon be published. Participating experts were selected in Europe and USA among those who have a treated patients and followed them up to observe multiple parameters (durability of efficacy, adverse events, etc.). The Delphi Consensus methodology is broadly used in medicine: first used in the 60’s, it has since then evolved and today is considered to be a reliable aproach, especially to assess new treatments. Under the coordination of urologists from the Careggi Hospital (University of Florence), experts thoroughly discussed selection and profiling of patients eligible for the treatment, shared their experiences and debated intra as well as post procedural options and recommendations. The publication of this work will reinforce and corroborate EchoLaser as a novel, but already well published, micro-invasive, outpatient treatment option available for patients affected by BPH and prostatic cancer.
EchoLaser and SuttonUnited
Our UK/IRE distributor Ideal Medical Systems (www.ideal-ms.com), advertised EchoLaser for BPH treatment with a dedicated signage at the stadium used by the UK football team Sutton United.
This initiative will increase awareness on the newest non surgical alternative to treat benign prostatic hyperplasia, a disease which heavily affects the male adult population above 45.
On this picture taken from a Sky TV interview The EchoLaser Stand in the back reaches a vast target audience, which will discuss alla available therapeutic solutions with their physicians, who will ultimately select the best for their patients.
